Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - CONCERT PHARMACEUTICALS, INC. | exhibit321.htm |
| EX-32.2 - EXHIBIT 32.2 - CONCERT PHARMACEUTICALS, INC. | exhibit322.htm |
| EX-10.21 - EXHIBIT 10.21 - CONCERT PHARMACEUTICALS, INC. | exhibit1021.htm |
| EX-31.2 - EXHIBIT 31.2 - CONCERT PHARMACEUTICALS, INC. | exhibit312.htm |
| EX-21.1 - EXHIBIT 21.1 - CONCERT PHARMACEUTICALS, INC. | exhibit211.htm |
| 10-K - 10-K - CONCERT PHARMACEUTICALS, INC. | cnce201510-k.htm |
| EX-31.1 - EXHIBIT 31.1 - CONCERT PHARMACEUTICALS, INC. | exhibit311.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-195125) pertaining to the Amended and Restated 2006 Stock Option and Grant Plan and 2014 Stock Incentive Plan of Concert Pharmaceuticals, Inc. and the Registration Statement (Form S-8 No. 333-202453) pertaining to the 2014 Stock Incentive Plan of Concert Pharmaceuticals, Inc. of our report dated March 1, 2016, with respect to the consolidated financial statements of Concert Pharmaceuticals, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2015.
/s/ Ernst & Young LLP
Boston, Massachusetts
March 1, 2016